| Year |
Citation |
Score |
| 2019 |
Issac MSM, Yousef E, Tahir MR, Gaboury LA. MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis. Neoplasia (New York, N.Y.). 21: 1015-1035. PMID 31476594 DOI: 10.1016/J.Neo.2019.07.011 |
0.391 |
|
| 2018 |
Goyette MA, Duhamel S, Aubert L, Pelletier A, Savage P, Thibault MP, Johnson RM, Carmeliet P, Basik M, Gaboury L, Muller WJ, Park M, Roux PP, Gratton JP, Côté JF. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression. Cell Reports. 23: 1476-1490. PMID 29719259 DOI: 10.1016/J.Celrep.2018.04.019 |
0.414 |
|
| 2018 |
Duhamel S, Goyette MA, Thibault MP, Filion D, Gaboury L, Côté JF. The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation. Cell Reports. 22: 1016-1030. PMID 29386124 DOI: 10.1016/J.Celrep.2017.12.096 |
0.364 |
|
| 2018 |
Medimegh I, Ayari H, Baraudi O, Majoul H, Omrane I, Yousef E, Benayed F, Benromdhan K, Gaboury L, Mader S, Benammarelgaaied A. Abstract P5-07-12: miR-34a as a prognostic biomarker for overall survival triple negative breast cancer within Tunisian patients Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P5-07-12 |
0.307 |
|
| 2017 |
Matsuda H, Campion CG, Fujiwara K, Ikeda J, Cossette S, Verissimo T, Ogasawara M, Gaboury L, Saito K, Yamaguchi K, Takahashi S, Endo M, Fukuda N, Soma M, Hamet P, et al. HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma. Oncotarget. 8: 69559-69576. PMID 29050225 DOI: 10.18632/Oncotarget.18012 |
0.338 |
|
| 2017 |
Chen L, Yuan Y, Kar S, Kanchi MM, Arora S, Kim JE, Koh PF, Yousef E, Samy RP, Shanmugam MK, Tan TZ, Shin SW, Arfuso F, Shen HM, Yang H, ... ... Gaboury L, et al. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. Molecular Cancer Therapeutics. PMID 29021293 DOI: 10.1158/1535-7163.Mct-16-0739 |
0.409 |
|
| 2017 |
Williams V, Grosset AA, Zamorano Cuervo N, St-Pierre Y, Sylvestre MP, Gaboury L, Grandvaux N. Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis. Bmc Cancer. 17: 356. PMID 28532474 DOI: 10.1186/S12885-017-3321-6 |
0.413 |
|
| 2017 |
Yousef EM, Furrer D, Laperriere DL, Tahir MR, Mader S, Diorio C, Gaboury LA. MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28084344 DOI: 10.1038/Modpathol.2016.231 |
0.406 |
|
| 2016 |
Grosset A, Poirier F, Gaboury L, St-Pierre Y. Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer. Plos One. 11. PMID 27902734 DOI: 10.1371/Journal.Pone.0166731 |
0.392 |
|
| 2016 |
Grosset AA, Labrie M, Vladoiu MC, Yousef EM, Gaboury L, St-Pierre Y. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. Oncotarget. 7: 18183-18203. PMID 26933916 DOI: 10.18632/Oncotarget.7784 |
0.418 |
|
| 2016 |
Schlienger S, Campbell S, Pasquin S, Gaboury L, Claing A. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Oncotarget. PMID 26908458 DOI: 10.18632/Oncotarget.7515 |
0.432 |
|
| 2016 |
Cai W, Cheong J, Edison E, Banerjee A, Tan T, Gaboury L, Yousef E, Thiery J, Lobie P, Virshup D, Yap C, Kumar A. Abstract P4-08-03: DEAD-box RNA helicase DP103 as a novel regulator of Wnt/β-catenin signaling pathway and promotes cancer stem cell-like behavior in triple negative breast cancers Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P4-08-03 |
0.382 |
|
| 2015 |
Trop I, Destrempes F, El Khoury M, Robidoux A, Gaboury L, Allard L, Chayer B, Cloutier G. The Added Value of Statistical Modeling of Backscatter Properties in the Management of Breast Lesions at US. Radiology. 275: 666-74. PMID 25496215 DOI: 10.1148/Radiol.14140318 |
0.31 |
|
| 2015 |
Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 258-64. PMID 25452445 DOI: 10.1200/Jco.2014.55.7827 |
0.325 |
|
| 2015 |
Labrie M, Vladoiu M, Leclerc BG, Grosset AA, Gaboury L, Stagg J, St-Pierre Y. A mutation in the carbohydrate recognition domain drives a phenotypic switch in the role of galectin-7 in prostate cancer Plos One. 10. DOI: 10.1371/Journal.Pone.0131307 |
0.345 |
|
| 2015 |
St-Pierre Y, Grosset A, Labrie M, Gagné D, Vladoiu M, Gaboury L, Doucet N. Abstract P1-07-16: Galectin-7 increases resistance of breast cancer cells to drug-induced apoptosis and promotes tumor escape by killing T cells Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-16 |
0.425 |
|
| 2014 |
Grosset AA, Labrie M, Gagné D, Vladoiu MC, Gaboury L, Doucet N, St-Pierre Y. Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells. Bmc Cancer. 14: 801. PMID 25367122 DOI: 10.1186/1471-2407-14-801 |
0.401 |
|
| 2014 |
Labrie M, Vladoiu MC, Grosset AA, Gaboury L, St-Pierre Y. Expression and functions of galectin-7 in ovarian cancer. Oncotarget. 5: 7705-7721. PMID 25277199 DOI: 10.18632/Oncotarget.2299 |
0.386 |
|
| 2014 |
Yousef EM, Tahir MR, St-Pierre Y, Gaboury LA. MMP-9 expression varies according to molecular subtypes of breast cancer. Bmc Cancer. 14: 609. PMID 25151367 DOI: 10.1186/1471-2407-14-609 |
0.382 |
|
| 2014 |
Shin EM, Hay HS, Lee MH, Goh JN, Tan TZ, Sen YP, Lim SW, Yousef EM, Ong HT, Thike AA, Kong X, Wu Z, Mendoz E, Sun W, Salto-Tellez M, ... ... Gaboury L, et al. DEAD-box helicase DP103 defines metastatic potential of human breast cancers. The Journal of Clinical Investigation. 124: 3807-24. PMID 25083991 DOI: 10.1172/Jci73451 |
0.394 |
|
| 2014 |
Labrie M, Vladoiu MC, Grosset A, Gaboury L, St-Pierre Y. Abstract 152: Galectin-7 increases the invasive behavior of ovarian cancer cells and promotes tumor escape Cancer Research. 74: 152-152. DOI: 10.1158/1538-7445.Am2014-152 |
0.398 |
|
| 2014 |
Grosset A, Gagné D, Labrie M, Vladoiu M, Gaboury L, Doucet N, St-Pierre Y. Abstract 1352: Cytoplasmic galectin-7 has an antiapoptotic function by decreasing p53 nuclear translocation in breast cancer cells Cancer Research. 74: 1352-1352. DOI: 10.1158/1538-7445.Am2014-1352 |
0.415 |
|
| 2013 |
Biron-Pain K, Grosset A, Poirier F, Gaboury L, St-Pierre Y. Expression and functions of galectin-7 in human and murine melanomas. Plos One. 8. PMID 23658821 DOI: 10.1371/Journal.Pone.0063307 |
0.415 |
|
| 2013 |
Gaboury LA. Deregulated Expression of ANXA1 in Human High-Grade Breast Cancers Journal of Molecular Biomarkers & Diagnosis. 4. DOI: 10.4172/2155-9929.1000155 |
0.414 |
|
| 2012 |
Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, Zuo D, Madore J, Monast A, Mes-Masson AM, Grosset AA, Gaboury L, Hallet M, Siegel P, Park M. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Research : Bcr. 14: R74. PMID 22569336 DOI: 10.1186/Bcr3183 |
0.429 |
|
| 2011 |
Trop I, David J, El Khoury M, Gautier N, Gaboury L, Lalonde L. Microcalcifications around a collagen-based breast biopsy marker: complication of biopsy with a percutaneous marking system. Ajr. American Journal of Roentgenology. 197: W353-7. PMID 21785065 DOI: 10.2214/Ajr.10.5783 |
0.311 |
|
| 2011 |
Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik M. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. International Journal of Cancer. Journal International Du Cancer. 129: 225-32. PMID 20830712 DOI: 10.1002/Ijc.25665 |
0.343 |
|
| 2011 |
Hanson ES, Fathers KE, Rajadurai CV, Monast A, Cory S, Zhao H, Zuo D, Grosset A, Gaboury L, Madore J, Hallett M, Siegel P, Park M. Abstract 918: A key role for Crk adaptor proteins in basal breast cancer tumor growth in vivo Cancer Research. 71: 918-918. DOI: 10.1158/1538-7445.Am2011-918 |
0.427 |
|
| 2010 |
Cavallone L, Arcand SL, Maugard CM, Nolet S, Gaboury LA, Mes-Masson AM, Ghadirian P, Provencher D, Tonin PN. Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer. Familial Cancer. 9: 507-17. PMID 20694749 DOI: 10.1007/S10689-010-9372-3 |
0.306 |
|
| 2010 |
Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, Petroulakis E, Robichaud N, Pollak M, Gaboury LA, Pandolfi PP, Saad F, Sonenberg N. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 107: 14134-9. PMID 20679199 DOI: 10.1073/Pnas.1005320107 |
0.304 |
|
| 2010 |
Demers M, Rose AA, Grosset AA, Biron-Pain K, Gaboury L, Siegel PM, St-Pierre Y. Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. The American Journal of Pathology. 176: 3023-31. PMID 20382700 DOI: 10.2353/Ajpath.2010.090876 |
0.44 |
|
| 2010 |
Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2147-56. PMID 20215530 DOI: 10.1158/1078-0432.Ccr-09-1611 |
0.414 |
|
| 2010 |
Pettersson F, Dobocan MC, Retrouvay H, Culjkovic B, Amri A, Gaboury L, Borden KLB, Miller WH. Abstract 3165: Anti-tumor activity of the eIF4E-targeted drug ribavirin in breast cancer cells Cancer Research. 70: 3165-3165. DOI: 10.1158/1538-7445.Am10-3165 |
0.426 |
|
| 2010 |
Rose A, Grosset A, Dong Z, Bertos N, Simantov R, Park M, Gaboury L, Siegel P. Abstract A8: GPNMB is an independent prognostic indicator of recurrence and a therapeutic target in triple negative breast cancer Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-A8 |
0.419 |
|
| 2009 |
Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M. The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer American Journal of Pathology. 175: 66-73. PMID 19497995 DOI: 10.2353/Ajpath.2009.080948 |
0.356 |
|
| 2009 |
Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M. Combination of low plasma stromal cell-derived factor-1 and phosphorylated-CXCR4: independent prognostic marker for breast cancer. Cancer Research. 69: 1069. DOI: 10.1158/0008-5472.Sabcs-1069 |
0.343 |
|
| 2009 |
Jolicoeur F, Fuente IGdl, Gaboury L, Balicki D. ALDH1 is a useful marker of basalness in human breast cancer and its stem/progenitor cells. Cancer Research. 69: 104. DOI: 10.1158/0008-5472.Sabcs-104 |
0.419 |
|
| 2008 |
Voisin L, Julien C, Duhamel S, Gopalbhai K, Claveau I, Saba-El-Leil MK, Rodrigue-Gervais IG, Gaboury L, Lamarre D, Basik M, Meloche S. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. Bmc Cancer. 8: 337. PMID 19014680 DOI: 10.1186/1471-2407-8-337 |
0.332 |
|
| 2007 |
Hanna W, O'malley FP, Barnes P, Berendt R, Gaboury L, Magliocco A, Pettigrew N, Robertson S, Sengupta S, Têtu B, Thomson T. Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Current Oncology (Toronto, Ont.). 14: 149-53. PMID 17710207 DOI: 10.3747/Co.2007.131 |
0.318 |
|
| 2007 |
Thériault M, Lalonde L, David J, Gaboury L, Trop I. Primary angiosarcoma of the breast Imagerie De La Femme. 17: 189-195. DOI: 10.1016/S1776-9817(07)92172-0 |
0.325 |
|
| 2007 |
Lalonde L, David J, Trop I, Gaboury L. Papillary lesions of the breast Imagerie De La Femme. 17: 229-246. DOI: 10.1016/S1776-9817(07)78168-3 |
0.327 |
|
| 2006 |
Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysis may be used to identify cancer stem cell populations. Experimental Cell Research. 312: 3701-10. PMID 17046749 DOI: 10.1016/J.Yexcr.2006.08.030 |
0.331 |
|
| 2003 |
Jolicoeur F, Gaboury LA, Oligny LL. Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 6: 398-413. PMID 14708733 DOI: 10.1007/S10024-003-1125-Y |
0.368 |
|
| 2002 |
Jolicoeur F, Seemayer TA, Gabbiani G, Robidoux A, Gaboury L, Oligny LL, Schürch W. Multifocal, nascent, and invasive myoepithelial carcinoma (malignant myoepithelioma) of the breast: an immunohistochemical and ultrastructural study. International Journal of Surgical Pathology. 10: 281-91. PMID 12490978 DOI: 10.1177/106689690201000406 |
0.343 |
|
| 1998 |
Krajinovic M, Richer C, Gorska-Flipot I, Gaboury L, Novakovic I, Labuda D, Sinnett D. Genomic loci susceptible to replication errors in cancer cells. British Journal of Cancer. 78: 981-5. PMID 9792139 DOI: 10.1038/Bjc.1998.616 |
0.356 |
|
| 1995 |
Daigneault L, Beaulieu R, Filion M, Gaboury L, Royal A, Babaï F. Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines. Clinical & Experimental Metastasis. 13: 345-56. PMID 7543834 DOI: 10.1007/Bf00121911 |
0.327 |
|
| 1988 |
Dedhar S, Gaboury L, Galloway P, Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proceedings of the National Academy of Sciences of the United States of America. 85: 9253-7. PMID 3057504 DOI: 10.1073/Pnas.85.23.9253 |
0.316 |
|
| Show low-probability matches. |